Perkins B D, Wensel T G, Vasquez K M, Wilson J H
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Biochemistry. 1999 Sep 28;38(39):12850-9. doi: 10.1021/bi9902743.
Targeting DNA damage by triplex-forming oligonucleotides (TFOs) represents a way of modifying gene expression and structure and a possible approach to gene therapy. We have determined that this approach can deliver damage with great specificity to sites in the human gene for the G-protein-linked receptor rhodopsin, mutations of which can lead to the genetic disorder autosomal dominant retinitis pigmentosa. We have introduced DNA monoadducts and interstrand cross-links at multiple target sites within the gene using TFOs with a photoactivatable psoralen group at the 5'-end. The extent of formation of photoadducts (i.e., monoadducts and cross-links) was measured at target sites with a 5'-ApT sequence at the triplex-duplex junction and at a target site with 5'-ApT and 5'-TpA sequences located four and seven nucleotides away, respectively. To improve psoralen reactivity at more distant sites, psoralen moieties were attached to TFOs with nucleotide "linkers" from two to nine nucleotides in length. High-affinity binding was maintained with linkers of up to 10 nucleotides, but affinities tended to decrease somewhat with increasing linker length due to faster dissociation kinetics. DNase I footprinting indicated little, if any, interaction between linkers and the duplex. Psoralen-TFO conjugates formed DNA cross-links with high efficiency (56-65%) at 5'-ApT sequences located at triplex junctions. At a 5'-ApT site four nucleotides away, the efficiency varied with linker length; a four-nucleotide linker gave the highest efficiency. Duplexes with 5'-TpA and 5'-ApT sites two nucleotides away, in otherwise identical sequences, were cross-linked with efficiencies of 56 and 38%, respectively. These results indicate that TFO-linker-psoralen conjugates allow simultaneous, efficient targeting of multiple sites in the human rhodopsin gene.
通过三链形成寡核苷酸(TFO)靶向DNA损伤代表了一种修饰基因表达和结构的方法以及一种可能的基因治疗途径。我们已经确定,这种方法可以将损伤高度特异性地传递到人基因中与G蛋白偶联受体视紫红质相关的位点,该基因的突变可导致遗传性疾病常染色体显性视网膜色素变性。我们使用在5'-末端带有可光活化补骨脂素基团的TFO,在该基因内的多个靶位点引入了DNA单加合物和链间交联。在三链-双链交界处具有5'-ApT序列的靶位点以及分别位于4个和7个核苷酸远处具有5'-ApT和5'-TpA序列的靶位点处,测量了光加合物(即单加合物和交联)的形成程度。为了提高补骨脂素在更远位点的反应活性,将补骨脂素部分连接到长度为2至9个核苷酸的核苷酸“接头”的TFO上。长达10个核苷酸的接头保持了高亲和力,但由于解离动力学加快,亲和力往往随着接头长度的增加而略有下降。DNase I足迹分析表明接头与双链体之间几乎没有相互作用。补骨脂素-TFO缀合物在位于三链交界处的5'-ApT序列处高效形成DNA交联(56-65%)。在4个核苷酸远处的5'-ApT位点,效率随接头长度而变化;4个核苷酸的接头效率最高。在其他方面相同的序列中,与5'-TpA和5'-ApT位点相距2个核苷酸的双链体分别以56%和38%的效率交联。这些结果表明,TFO-接头-补骨脂素缀合物能够同时高效地靶向人视紫红质基因中的多个位点。